SEC Form 4 · accession 0001144204-17-062472
Ensysce Biosciences, Inc. · ENSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Daniel B. Silvers
Officer — Chief Executive Officer · Director
MLCP GLL Funding LLC
Other
Period of report
Dec 5, 2017
Accepted (ET)
Dec 5, 2017 · 6:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001716947
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Dec 5, 2017 | J | 359,869 | $0.00 | D | 1,300,202 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1As contemplated by the securities subscription agreement between each reporting person and the Company, 359,869 shares held by MLCP GLL Funding LLC, an affiliate of a sponsor of the Company (the "Sponsor Affiliate") and Matthews Lane Capital Partners LLC, a sponsor of the Company (the "Sponsor"), were forfeited upon consummation of the Company's initial public offering for no consideration.
- F2Includes an aggregate of 171,833 shares held by the Sponsor Affiliate and the Sponsor that are subject to forfeiture to the extent that the underwriters' overallotment in the Company's initial public offering is not fully exercised.
- F3Represents 1,022,222 shares of common stock held by the Sponsor Affiliate. Represents 277,980 shares of common stock held by the Sponsor. The shares held by the Sponsor Affiliate and the Sponsor are beneficially owned by Daniel B. Silvers, who has sole voting and dispositive power over the shares held by the Sponsor Affiliate and the Sponsor. Mr. Silvers owns all of the membership interests in the Sponsor Affiliate and the Sponsor. Mr. Silvers disclaims beneficial ownership over any securities owned by the Sponsor and the Sponsor Affiliate in which he does not have any pecuniary interest.